ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Zometa Prevents Bone Loss In Premenopausal Women

August 29, 2008

Funding Opportunities.

May 3, 2002

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

September 19, 1986

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980

Cancer Trials Take 800 Days To Start On Average; NCI Vows Improvement.

April 11, 2008

Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data

November 22, 2013